IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy

Publisher DOI
PubMed ID
20667861
Description
The pathogenesis of multifocal motor neuropathy (MMN) has yet to be established. MMN patients often carry anti-GM1 IgM antibodies, suggesting an autoimmune process involving complement. Intravenous immunoglobulin (IVIG) is the first line treatment, but its action mechanism is unknown.
Date of Publication
2011
Publication Type
Article
Language(s)
en
Contributor(s)
Yuki, N
Watanabe, H
Nakajima, T
Additional Credits
Series
Journal of neurology, neurosurgery and psychiatry
Publisher
BMJ Publishing Group
ISSN
0022-3050
Access(Rights)
metadata.only
Show full item